世界における脊髄刺激装置の製品パイプライン動向2015

GlobalDataが発行した調査報告書(GDME0095EPD)
◆英語タイトル:Spinal Cord Stimulators - Pipeline Review, 2015
◆商品コード:GDME0095EPD
◆発行会社(リサーチ会社):GlobalData
◆発行日:2015年10月19日
◆ページ数:107
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥847,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

当調査レポートでは、脊髄刺激装置のグローバル製品パイプライン動向について調査・分析し、以下の構成でお届けいたします。

・脊髄刺激装置の概要
・脊髄刺激装置の開発動向:開発段階別分析
・脊髄刺激装置の開発動向:領域別分析
・脊髄刺激装置の開発動向:規制Path別分析
・脊髄刺激装置の開発動向:承認日(推定)別分析
・企業別脊髄刺激装置の開発動向(パイプライン製品、進行中の治験)
・脊髄刺激装置の最近動向
【レポートの概要】

Spinal Cord Stimulators – Pipeline Review, 2015

Summary

GlobalData’s Medical Devices sector report, “Spinal Cord Stimulators – Pipeline Review, 2015″ provides an overview of Spinal Cord Stimulators currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Spinal Cord Stimulators pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Spinal Cord Stimulators under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Spinal Cord Stimulators and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Spinal Cord Stimulators under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 6
2 Introduction 7
2.1 Spinal Cord Stimulators Overview 7
3 Products under Development 8
3.1 Spinal Cord Stimulators – Pipeline Products by Stage of Development 8
3.2 Spinal Cord Stimulators – Pipeline Products by Territory 9
3.3 Spinal Cord Stimulators – Pipeline Products by Regulatory Path 10
3.4 Spinal Cord Stimulators – Pipeline Products by Estimated Approval Date 11
3.5 Spinal Cord Stimulators – Ongoing Clinical Trials 12
4 Spinal Cord Stimulators – Pipeline Products under Development by Companies 13
4.1 Spinal Cord Stimulators Companies – Pipeline Products by Stage of Development 13
4.2 Spinal Cord Stimulators – Pipeline Products by Stage of Development 14
5 Spinal Cord Stimulators Companies and Product Overview 15
5.1 Boston Scientific Corporation Company Overview 15
5.1.1 Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 15
5.2 Direct Spinal Therapeutics, Inc. Company Overview 19
5.2.1 Direct Spinal Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19
5.3 Duke University Company Overview 20
5.3.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 20
5.4 Imperial College London Company Overview 23
5.4.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 23
5.5 Meagan Medical Inc. Company Overview 24
5.5.1 Meagan Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
5.6 Medtrode Inc. Company Overview 25
5.6.1 Medtrode Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
5.7 Medtronic plc Company Overview 27
5.7.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 27
5.8 MicroTransponder Inc. Company Overview 35
5.8.1 MicroTransponder Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
5.9 NeuroRecovery Technologies Inc. Company Overview 37
5.9.1 NeuroRecovery Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
5.10 Nuvectra Corporation Company Overview 39
5.10.1 Nuvectra Corporation Pipeline Products & Ongoing Clinical Trials Overview 39
5.11 Saluda Medical Pty Ltd Company Overview 42
5.11.1 Saluda Medical Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 42
5.12 St. Jude Medical, Inc. Company Overview 43
5.12.1 St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43
5.13 Stimwave Technologies, Inc. Company Overview 60
5.13.1 Stimwave Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60
6 Spinal Cord Stimulators- Recent Developments 63
7 Appendix 104
7.1 Methodology 104
7.2 About GlobalData 106
7.3 Contact Us 107
7.4 Disclaimer 107

1.1 List of Tables
Table 1: Spinal Cord Stimulators - Pipeline Products by Stage of Development 8
Table 2: Spinal Cord Stimulators - Pipeline Products by Territory 9
Table 3: Spinal Cord Stimulators - Pipeline Products by Regulatory Path 10
Table 4: Spinal Cord Stimulators - Pipeline Products by Estimated Approval Date 11
Table 5: Spinal Cord Stimulators - Ongoing Clinical Trials 12
Table 6: Spinal Cord Stimulators Companies - Pipeline Products by Stage of Development 13
Table 7: Spinal Cord Stimulators - Pipeline Products by Stage of Development 14
Table 8: Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 15
Table 9: Precision Implantable Neurostimulator - Migraine - Product Status 15
Table 10: Precision Implantable Neurostimulator - Migraine - Product Description 16
Table 11: Boston Scientific Corporation - Ongoing Clinical Trials Overview 17
Table 12: Precision Implantable Neurostimulator - Migraine - Occipital Nerve Stimulation (ONS) for Migraine OPTIMISE 18
Table 13: Precision Implantable Neurostimulator - Migraine - Two-years Follow-up of Post-spinal Implantable Neurostimulator PRECISION 18
Table 14: Direct Spinal Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19
Table 15: Iowa-Patch System - Product Status 19
Table 16: Iowa-Patch System - Product Description 19
Table 17: Duke University Pipeline Products & Ongoing Clinical Trials Overview 20
Table 18: Spinal Cord Stimulator - Product Status 20
Table 19: Spinal Cord Stimulator - Product Description 20
Table 20: Duke University - Ongoing Clinical Trials Overview 21
Table 21: Spinal Cord Stimulator - Pain Coping Skills Training for Spinal Cord Stimulator Implant Candidates 22
Table 22: Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 23
Table 23: Wireless Intraspinal Microstimulation System - Product Status 23
Table 24: Wireless Intraspinal Microstimulation System - Product Description 23
Table 25: Meagan Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
Table 26: DISCSS IFC System - Product Status 24
Table 27: DISCSS IFC System - Product Description 24
Table 28: Medtrode Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
Table 29: Implantable Pulse Generator - Product Status 26
Table 30: Implantable Pulse Generator - Product Description 26
Table 31: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 27
Table 32: Intellis RC - Product Status 28
Table 33: Intellis RC - Product Description 28
Table 34: MRI Surgical Lead - Product Status 29
Table 35: MRI Surgical Lead - Product Description 29
Table 36: PNS Device - Chronic Back Pain - Product Status 30
Table 37: PNS Device - Chronic Back Pain - Product Description 30
Table 38: PrimeADVANCED - Heart Failure - Product Status 31
Table 39: PrimeADVANCED - Heart Failure - Product Description 31
Table 40: Medtronic plc - Ongoing Clinical Trials Overview 32
Table 41: PrimeADVANCED - Heart Failure - Determining the Feasibility of Spinal Cord Neuromodulation for the Treatment of Chronic Heart Failure 33
Table 42: PNS Device - Chronic Back Pain - Interventional, Prospective, Multi-Center, Randomized, Parallel-arm Study to Compare the Effectiveness of Peripheral Nerve Stimulation (PNS) Utilizing a Subcutaneous Lead Implant Technique (SQS) Plus Optimized Medical Management (OMM) Versus OMM Alone in Patients Suffering From Back Pain Due to Failed Back Surgery Syndrome (FBSS) 34
Table 43: MicroTransponder Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
Table 44: SAINT System - Chronic Pain - Product Status 36
Table 45: SAINT System - Chronic Pain - Product Description 36
Table 46: NeuroRecovery Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
Table 47: External Spinal Cord Neuromodulation System - Product Status 37
Table 48: External Spinal Cord Neuromodulation System - Product Description 37
Table 49: Spinal Cord Stimulation Device - Product Status 38
Table 50: Spinal Cord Stimulation Device - Product Description 38
Table 51: Nuvectra Corporation Pipeline Products & Ongoing Clinical Trials Overview 39
Table 52: Algovita System - Product Status 39
Table 53: Algovita System - Product Description 39
Table 54: Nuvectra Corporation - Ongoing Clinical Trials Overview 40
Table 55: Algovita System - Real-world Evaluation of Outcome Data Under a Prospective, Observational, Post-Market Clinical Study, Using the Algovita SCS System to Treat Patients With Chronic Pain of the Trunk and/or Limbs Per the Applicable Indications for Use 41
Table 56: Saluda Medical Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 42
Table 57: Evoke Spinal Cord Stimulation System - Product Status 42
Table 58: Evoke Spinal Cord Stimulation System - Product Description 42
Table 59: St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43
Table 60: Axium Spinal Cord Stimulation System - Product Status 43
Table 61: Axium Spinal Cord Stimulation System - Product Description 44
Table 62: Next Generation Implantable SCS System - Primary Cell - Product Status 44
Table 63: Next Generation Implantable SCS System - Primary Cell - Product Description 44
Table 64: Next Generation Implantable SCS System - Rechargeable - Product Status 45
Table 65: Next Generation Implantable SCS System - Rechargeable - Product Description 45
Table 66: Proclaim DRG - Product Status 46
Table 67: Proclaim DRG - Product Description 46
Table 68: Proclaim Rechargeable Model - Product Status 47
Table 69: Proclaim Rechargeable Model - Product Description 47
Table 70: Proclaim SCS - Product Status 48
Table 71: Proclaim SCS - Product Description 48
Table 72: Proclaim Upgrade HC - Product Status 49
Table 73: Proclaim Upgrade HC - Product Description 49
Table 74: Proclaim Upgrade LC - Product Status 50
Table 75: Proclaim Upgrade LC - Product Description 50
Table 76: Prodigy SCS System - Product Status 51
Table 77: Prodigy SCS System - Product Description 51
Table 78: St. Jude Medical, Inc. - Ongoing Clinical Trials Overview 52
Table 79: Axium Spinal Cord Stimulation System - A BavariAn Evaluation of DRG Stimulation for the Treatment for Chronic Post Surgical Pain of the Groin 54
Table 80: Axium Spinal Cord Stimulation System - A Post Market Cohort to Assess the Performance of the Spinal Modulation Neurostimulator System for the Management of Chronic Intractable Pain 54
Table 81: Axium Spinal Cord Stimulation System - A Post Market Cohort to Assess the Performance of the Spinal Modulation Neurostimulator System for the Management of Chronic Neuropathic Pain of the Foot and/or Lower Leg 54
Table 82: Axium Spinal Cord Stimulation System - A Post Market Cohort with the Commercially Available Spinal Modulation Neurostimulator System for the Management of Peripheral Neuropathy 55
Table 83: Axium Spinal Cord Stimulation System - A Post Market Observational Cohort Study to Assess the Performance of the Spinal Modulation Dorsal Root Ganglion Stimulator System for the Management of Chronic Post Surgical Pain 55
Table 84: Axium Spinal Cord Stimulation System - A Post Market Observational Study on the Effect of DRG Stimulation in Patients with Chronic Pain Following Surgical Lumbar Discectomy (Failed Back Surgery Syndrome): SYMPATHY 55
Table 85: Axium Spinal Cord Stimulation System - A Prospective Post Market Trial of DRG stiImulation with the Commercially Available Axium 56
Table 86: Axium Spinal Cord Stimulation System - A Prospective, Randomized, Multi-center, Controlled Clinical Trial to Assess the Safety and Efficacy of the Spinal Modulation AXIUM Neurostimulator System in the Treatment of Chronic Pain (ACCURATE Trial) 56
Table 87: Axium Spinal Cord Stimulation System - A Randomised Pilot Study to Assess Differences in the Subjects' Experience of Stimulation-induced Paraesthesia Between Two Different Spinal Cord Stimulation Devices: The Axium Dorsal Root Ganglion Stimulation System versus the Prime Advanced Dorsal Column Stimulation System (CHARACTER SCS) 57
Table 88: Axium Spinal Cord Stimulation System - A Randomized Controlled Trial to Evaluate the Efficacy of the Spinal Modulation Axium Neurostimulator Therapy as a Treatment for Persistent Inguinal Pain Following Surgical Intervention 57
Table 89: Axium Spinal Cord Stimulation System - BINGO: A Post Market Evaluation of Chronic intractable Pain and the Efficacy of DRG stimulation in the Nordic Region 58
Table 90: Axium Spinal Cord Stimulation System - Clinical Study Protocol Dorsal Root Ganglion Stimulation for the Management of Painful Intractable Small Fibre Neuropathy 58
Table 91: Prodigy SCS System - A Post-market Study Evaluating the Prodigy Neuromodulation System for the Management of Failed Back Surgery Syndrome or Chronic Intractable Pain of the Trunk and/or Limbs 59
Table 92: Prodigy SCS System - Success Using Neuromodulation with BURST (SUNBURST) Study 59
Table 93: Stimwave Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60
Table 94: Freedom-8 SCS System - Product Status 60
Table 95: Freedom-8 SCS System - Product Description 60
Table 96: Stimwave Technologies, Inc. - Ongoing Clinical Trials Overview 61
Table 97: Freedom-8 SCS System - Stimwave Freedom Eight-electrode, Multi-programmable Wireless Miniature Injectable Stimulator for Relief of Chronic Back and Leg Pain 62
Table 98: Glossary 105

1.2 List of Figures
Figure 1: Spinal Cord Stimulators - Pipeline Products by Stage of Development 8
Figure 2: Spinal Cord Stimulators - Pipeline Products by Territory 9
Figure 3: Spinal Cord Stimulators - Pipeline Products by Regulatory Path 10
Figure 4: Spinal Cord Stimulators - Pipeline Products by Estimated Approval Date 11
Figure 5: Spinal Cord Stimulators - Ongoing Clinical Trials 12

【掲載企業】

Boston Scientific Corporation
Direct Spinal Therapeutics, Inc.
Duke University
Imperial College London
Meagan Medical Inc.
Medtrode Inc.
Medtronic plc
MicroTransponder Inc.
NeuroRecovery Technologies Inc.
Nuvectra Corporation
Saluda Medical Pty Ltd
St. Jude Medical, Inc.
Stimwave Technologies, Inc.

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界における脊髄刺激装置の製品パイプライン動向2015(Spinal Cord Stimulators - Pipeline Review, 2015)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆